TP006/#1565 Dose-expansion part of a phase 1b global study of E7386 plus lenvatinib in patients with hepatocellular carcinoma and other solid tumors including endometrial cancer — Jung-Yun Lee (2024) | RDL Network
TP006/#1565 Dose-expansion part of a phase 1b global study of E7386 plus lenvatinib in patients with hepatocellular carcinoma and other solid tumors including endometrial cancer
Richard S. Finn, Masafumi Ikeda, Andrew X. Zhu, Max W. Sung, Ari David Baron, Masatoshi Kudo, Takuji Okusaka, Masahiro Kobayashi, Hiromitsu Kumada, Shuichi Kaneko, Marc Pracht, K. G Mamontov, Tim Meyer, Kalgi Mody, Tomoki Kubota, Corina E. Dutcus, Kenichi Saito, Abby B. Siegel, Leonid Dubrovsky, Josep M. Llovet
Masatoshi Kudo, Richard S. Finn, Masafumi Ikeda, Max W. Sung, Ari David Baron, Takuji Okusaka, Masahiro Kobayashi, Hiromitsu Kumada, Shuichi Kaneko, Marc Pracht, Tim Meyer, Satoshi Nagao, Kenichi Saito, Kalgi Mody, Zahra Ramji, Leonid Dubrovsky, Josep M. Llovet
Masafumi Ikeda, Max W. Sung, Masatoshi Kudo, Masahiro Kobayashi, Ari David Baron, Richard S. Finn, Shuichi Kaneko, Andrew X. Zhu, Tomoki Kubota, Silvija Kraljevic, Kohei Ishikawa, Abby B. Siegel, Hiromitsu Kumada, Takuji Okusaka
Discussion(0)
No comments yet. Be the first to comment.